Pulmuone Co., Ltd. Logo

Pulmuone Co., Ltd.

017810.KS

(1.2)
Stock Price

11.410,00 KRW

0.63% ROA

6.78% ROE

29.87x PER

Market Cap.

385.958.887.110,00 KRW

955.88% DER

0.97% Yield

0.42% NPM

Pulmuone Co., Ltd. Stock Analysis

Pulmuone Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Pulmuone Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

2 PBV

The stock's PBV ratio (1.16x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 Buffet Intrinsic Value

The company's stock seems undervalued (27.832.097) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

5 ROE

Negative ROE (-8.64%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-1.81%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 DER

The stock is burdened with a heavy load of debt (329%), making it financially unstable and potentially risky for investors.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Pulmuone Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Pulmuone Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Pulmuone Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Pulmuone Co., Ltd. Revenue
Year Revenue Growth
2007 729.103.291.000
2008 897.333.142.000 18.75%
2009 1.120.365.401.000 19.91%
2010 1.272.688.991.430 11.97%
2011 1.370.528.859.950 7.14%
2012 1.457.884.335.530 5.99%
2013 1.521.708.340.200 4.19%
2014 1.678.094.350.000 9.32%
2015 1.846.488.476.990 9.12%
2016 2.030.673.097.850 9.07%
2017 2.238.114.683.310 9.27%
2018 2.271.973.131.850 1.49%
2019 2.381.451.203.140 4.6%
2020 2.311.199.992.420 -3.04%
2021 2.518.896.106.070 8.25%
2022 2.838.303.860.360 11.25%
2023 2.984.232.308.000 4.89%
2023 2.993.468.191.302 0.31%
2024 3.172.195.814.036 5.63%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Pulmuone Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2007 6.316.980.000
2008 5.721.980.000 -10.4%
2009 8.528.894.740 32.91%
2010 10.248.219.000 16.78%
2011 11.908.477.000 13.94%
2012 13.949.682.000 14.63%
2013 14.735.613.000 5.33%
2014 16.664.850.000 11.58%
2015 18.313.611.000 9%
2016 19.936.975.000 8.14%
2017 20.861.888.000 4.43%
2018 23.452.281.000 11.05%
2019 26.789.475.000 12.46%
2020 32.927.354.000 18.64%
2021 28.289.087.000 -16.4%
2022 27.629.783.000 -2.39%
2023 0 0%
2023 29.866.690.710 100%
2024 31.043.801.928 3.79%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Pulmuone Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 9.110.748.000
2008 11.430.907.000 20.3%
2009 191.484.105.250 94.03%
2010 215.499.743.000 11.14%
2011 15.184.843.000 -1319.18%
2012 16.262.611.000 6.63%
2013 18.206.481.000 10.68%
2014 16.412.352.000 -10.93%
2015 31.860.290.000 48.49%
2016 37.494.444.000 15.03%
2017 34.256.351.000 -9.45%
2018 33.863.964.000 -1.16%
2019 33.784.774.000 -0.23%
2020 30.545.789.000 -10.6%
2021 35.637.914.000 14.29%
2022 29.457.330.000 -20.98%
2023 698.222.696.000 95.78%
2023 32.047.388.000 -2078.72%
2024 737.713.036.000 95.66%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Pulmuone Co., Ltd. EBITDA
Year EBITDA Growth
2007 65.988.053.000
2008 76.856.580.000 14.14%
2009 76.338.064.010 -0.68%
2010 67.805.892.770 -12.58%
2011 92.696.744.840 26.85%
2012 97.449.615.030 4.88%
2013 97.175.062.460 -0.28%
2014 152.945.842.570 36.46%
2015 101.268.128.820 -51.03%
2016 106.451.855.950 4.87%
2017 132.115.561.180 19.43%
2018 124.617.291.210 -6.02%
2019 148.931.317.750 16.33%
2020 176.639.909.480 15.69%
2021 182.600.667.810 3.26%
2022 178.743.559.950 -2.16%
2023 785.814.580.000 77.25%
2023 209.737.858.380 -274.67%
2024 225.304.802.760 6.91%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Pulmuone Co., Ltd. Gross Profit
Year Gross Profit Growth
2007 191.706.924.000
2008 206.188.394.000 7.02%
2009 291.667.925.000 29.31%
2010 351.574.067.430 17.04%
2011 375.263.710.800 6.31%
2012 397.390.432.160 5.57%
2013 424.490.185.110 6.38%
2014 472.810.726.010 10.22%
2015 489.329.108.390 3.38%
2016 540.896.975.300 9.53%
2017 586.372.341.390 7.76%
2018 559.030.582.550 -4.89%
2019 590.024.047.760 5.25%
2020 611.494.180.120 3.51%
2021 656.234.720.750 6.82%
2022 700.418.644.570 6.31%
2023 785.814.580.000 10.87%
2023 726.666.067.120 -8.14%
2024 777.956.065.940 6.59%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Pulmuone Co., Ltd. Net Profit
Year Net Profit Growth
2007 26.576.426.000
2008 17.080.360.000 -55.6%
2009 18.230.939.230 6.31%
2010 6.267.929.000 -190.86%
2011 17.158.879.000 63.47%
2012 9.902.985.150 -73.27%
2013 -6.298.626.390 257.22%
2014 55.022.584.970 111.45%
2015 20.318.977.770 -170.79%
2016 18.594.717.750 -9.27%
2017 38.505.585.660 51.71%
2018 23.419.481.530 -64.42%
2019 -7.535.425.360 410.79%
2020 11.833.778.470 163.68%
2021 304.155.970 -3790.69%
2022 -36.967.492.000 100.82%
2023 34.420.136.000 207.4%
2023 9.365.091.490 -267.54%
2024 7.179.480.824 -30.44%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Pulmuone Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 1.361
2008 445 -205.84%
2009 494 9.92%
2010 170 -192.31%
2011 464 63.58%
2012 268 -73.78%
2013 -170 257.06%
2014 1.480 111.49%
2015 546 -171.56%
2016 499 -9.22%
2017 1.034 51.69%
2018 55 -1778.18%
2019 -202 127.23%
2020 318 163.72%
2021 8 -3862.5%
2022 -1.005 100.8%
2023 936 207.37%
2023 255 -268.5%
2024 195 -30.26%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Pulmuone Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2007 4.957.291.000
2008 -29.608.288.000 116.74%
2009 -32.113.771.210 7.8%
2010 -79.665.601.360 59.69%
2011 -57.221.513.830 -39.22%
2012 5.286.402.260 1182.43%
2013 48.685.744.270 89.14%
2014 32.100.302.030 -51.67%
2015 36.008.903.730 10.85%
2016 -15.621.186.570 330.51%
2017 -47.568.225.390 67.16%
2018 -38.698.573.730 -22.92%
2019 -42.630.392.770 9.22%
2020 -45.925.319.350 7.17%
2021 -104.719.671.660 56.14%
2022 -52.601.919.370 -99.08%
2023 66.157.241.633 179.51%
2023 43.119.651.070 -53.43%
2024 26.242.994.561 -64.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Pulmuone Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2007 46.353.605.000
2008 24.999.279.000 -85.42%
2009 50.565.691.250 50.56%
2010 6.724.485.680 -651.96%
2011 48.299.546.410 86.08%
2012 70.941.620.560 31.92%
2013 111.376.933.010 36.3%
2014 82.173.856.650 -35.54%
2015 106.415.037.000 22.78%
2016 57.936.786.190 -83.67%
2017 62.647.958.310 7.52%
2018 59.290.674.270 -5.66%
2019 85.410.376.720 30.58%
2020 103.960.982.420 17.84%
2021 118.483.163.530 12.26%
2022 94.837.568.160 -24.93%
2023 193.580.429.927 51.01%
2023 75.659.279.450 -155.86%
2024 47.918.017.564 -57.89%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Pulmuone Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2007 41.396.314.000
2008 54.607.567.000 24.19%
2009 82.679.462.460 33.95%
2010 86.390.087.040 4.3%
2011 105.521.060.240 18.13%
2012 65.655.218.300 -60.72%
2013 62.691.188.740 -4.73%
2014 50.073.554.620 -25.2%
2015 70.406.133.270 28.88%
2016 73.557.972.760 4.28%
2017 110.216.183.700 33.26%
2018 97.989.248.000 -12.48%
2019 128.040.769.490 23.47%
2020 149.886.301.770 14.57%
2021 223.202.835.190 32.85%
2022 147.439.487.530 -51.39%
2023 127.423.188.294 -15.71%
2023 32.539.628.380 -291.59%
2024 21.675.023.003 -50.13%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Pulmuone Co., Ltd. Equity
Year Equity Growth
2007 181.938.395.000
2008 172.963.661.000 -5.19%
2009 191.383.593.330 9.62%
2010 190.943.670.320 -0.23%
2011 288.703.668.790 33.86%
2012 289.159.341.670 0.16%
2013 272.318.871.000 -6.18%
2014 334.693.236.580 18.64%
2015 330.352.653.370 -1.31%
2016 366.237.337.640 9.8%
2017 375.829.869.720 2.55%
2018 439.783.341.010 14.54%
2019 463.101.959.710 5.04%
2020 512.938.526.870 9.72%
2021 589.790.958.580 13.03%
2022 546.646.770.240 -7.89%
2023 535.925.490.000 -2%
2023 337.190.475.028 -58.94%
2024 338.500.966.641 0.39%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Pulmuone Co., Ltd. Assets
Year Assets Growth
2007 383.335.807.000
2008 518.154.804.000 26.02%
2009 665.910.002.490 22.19%
2010 731.553.882.840 8.97%
2011 926.334.533.740 21.03%
2012 1.025.509.528.420 9.67%
2013 981.371.865.740 -4.5%
2014 1.053.567.588.640 6.85%
2015 975.950.980.500 -7.95%
2016 1.061.384.109.100 8.05%
2017 1.103.028.814.900 3.78%
2018 1.214.578.439.820 9.18%
2019 1.484.556.453.750 18.19%
2020 1.693.573.176.270 12.34%
2021 1.969.372.521.100 14%
2022 2.049.217.755.230 3.9%
2023 2.107.247.234.000 2.75%
2023 2.156.789.583.389 2.3%
2024 2.140.828.368.914 -0.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Pulmuone Co., Ltd. Liabilities
Year Liabilities Growth
2007 201.397.412.000
2008 345.191.143.000 41.66%
2009 474.526.409.360 27.26%
2010 540.610.212.760 12.22%
2011 637.630.865.030 15.22%
2012 736.350.187.510 13.41%
2013 709.052.994.440 -3.85%
2014 718.874.352.190 1.37%
2015 645.598.327.140 -11.35%
2016 695.146.771.470 7.13%
2017 727.198.945.180 4.41%
2018 774.795.098.810 6.14%
2019 1.021.454.494.040 24.15%
2020 1.180.634.649.400 13.48%
2021 1.379.581.562.520 14.42%
2022 1.502.570.984.980 8.19%
2023 1.571.321.744.000 4.38%
2023 1.819.599.108.362 13.64%
2024 1.802.327.402.273 -0.96%

Pulmuone Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
83500.53
Net Income per Share
350.51
Price to Earning Ratio
29.87x
Price To Sales Ratio
0.13x
POCF Ratio
2.99
PFCF Ratio
17.26
Price to Book Ratio
3.53
EV to Sales
0.53
EV Over EBITDA
4.59
EV to Operating CashFlow
12.73
EV to FreeCashFlow
73.33
Earnings Yield
0.03
FreeCashFlow Yield
0.06
Market Cap
385,96 Bil.
Enterprise Value
1.640,00 Bil.
Graham Number
4838.18
Graham NetNet
-35464.13

Income Statement Metrics

Net Income per Share
350.51
Income Quality
11.24
ROE
0.07
Return On Assets
0.01
Return On Capital Employed
0.06
Net Income per EBT
0.75
EBT Per Ebit
0.26
Ebit per Revenue
0.02
Effective Tax Rate
0.1

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.25
Operating Profit Margin
0.02
Pretax Profit Margin
0.01
Net Profit Margin
0

Dividends

Dividend Yield
0.01
Dividend Yield %
0.97
Payout Ratio
1.51
Dividend Per Share
102

Operating Metrics

Operating Cashflow per Share
3502.68
Free CashFlow per Share
608.23
Capex to Operating CashFlow
0.83
Capex to Revenue
0.03
Capex to Depreciation
0.68
Return on Invested Capital
0.05
Return on Tangible Assets
0.01
Days Sales Outstanding
36.13
Days Payables Outstanding
31.1
Days of Inventory on Hand
28.17
Receivables Turnover
10.1
Payables Turnover
11.74
Inventory Turnover
12.96
Capex per Share
2894.45

Balance Sheet

Cash per Share
4.919,54
Book Value per Share
9.205,69
Tangible Book Value per Share
6626.61
Shareholders Equity per Share
2968.08
Interest Debt per Share
30050.64
Debt to Equity
9.56
Debt to Assets
0.49
Net Debt to EBITDA
3.51
Current Ratio
0.71
Tangible Asset Value
243,67 Bil.
Net Current Asset Value
-1.098,89 Bil.
Invested Capital
1016167754012
Working Capital
-292,66 Bil.
Intangibles to Total Assets
0.04
Average Receivables
305,28 Bil.
Average Payables
196,54 Bil.
Average Inventory
174425223461
Debt to Market Cap
2.7

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Pulmuone Co., Ltd. Dividends
Year Dividends Growth
2000 400
2001 650 38.46%
2002 800 18.75%
2003 760 -5.26%
2004 500 -52%
2005 600 16.67%
2006 720 16.67%
2007 1.070 32.71%
2008 1.070 0%
2009 1.020 -4.9%
2010 1.020 0%
2011 1.020 0%
2012 1.020 0%
2013 1.020 0%
2014 1.020 0%
2015 1.020 0%
2016 1.020 0%
2017 1.153 11.54%
2018 1.020 -13.04%
2019 102 -900%
2020 102 0%
2021 102 0%
2022 102 0%
2023 102 0%

Pulmuone Co., Ltd. Profile

About Pulmuone Co., Ltd.

Pulmuone Co., Ltd. produces, sells, and distributes fresh foods and beverages in South Korea and internationally. It provides functional foods, whole food, mineral water, and fermented milk products, as well as meal, concession, and catering services. The company was founded in 1981 and is headquartered in Eumseong-eup, South Korea.

CEO
Mr. Hyo-Yul Lee
Employee
487
Address
730-27 Samyang-ro
Eumseong-eup,

Pulmuone Co., Ltd. Executives & BODs

Pulmuone Co., Ltd. Executives & BODs
# Name Age
1 Mr. Yoon-Woo Han
President and Head of Strategic Management Division
70
2 Mr. Hyo-Yul Lee
Chief Executive Officer & Executive Director
70
3 Mr. Soon Lee
Head of HR Planning Department and Vice President
70

Pulmuone Co., Ltd. Competitors

Nongshim Co., Ltd. Logo
Nongshim Co., Ltd.

004370.KS

(3.0)
SK Telecom Co.,Ltd Logo
SK Telecom Co.,Ltd

017670.KS

(2.2)
LG H&H Co., Ltd. Logo
LG H&H Co., Ltd.

051900.KS

(1.5)
SHINSEGAE Inc. Logo
SHINSEGAE Inc.

004170.KS

(1.5)
CJ Corporation Logo
CJ Corporation

001040.KS

(1.8)